References
- Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
- Denas G, Jose SP, Bracco A, Zoppellaro G, Pengo V. Antiphospholipid syndrome and the heart: A case series and literature review. Autoimmun Rev 2015;14:214–22.
- Noureldine MHA, Nour-Eldine W, Khamashta MA, Uthman I. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. Semin Arthritis Rheum. Published online: 23 August 2018. doi:10.1016/j.semarthrit.2018.08.004.
- Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 2014;371:303–12.
- Kattwinkel N, Villanueva AG, Labib SB, Aretz HT, Walek JW, Burns DL, et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992;116:974–6.
- Vaccaro F, Caccavo D, Roumpedaki E, De Vincentis G, Di Gioia CRT, Gallo P, et al. Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report. Int J Immunopathol Pharmacol 2008;21:237–41.
- Bosello S, De Luca G, Ferraccioli G. Troponin in stable ischemic heart disease and diabetes. N Engl J Med 2015;373:1977–8.
- Peretto G, Sala S, Rizzo S, De Luca G, Campochiaro C, Sartorelli S, et al. Arrhythmias in myocarditis: state of the art. Hear Rhythm. Published online: 23 November 2018. doi:10.1016/j.hrthm.2018.11.024.
- Peretto G, Sala S, De Luca G, Campochiaro C, Sartorelli S, Cappelletti AM, et al. Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis. Int J Cardiol. Published online: 21 November 2018. doi:10.1016/j.ijcard.2018.11.104.
- Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, et al. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Eur J Intern Med. Published online: 23 October 2018. doi:10.1016/j.ejim.2018.10.013.